References
Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P (2018) Diagnostic approach to low-renin hypertension. Clin Endocrinol 89:385–396
Al-Harbi T, Al-Shaikh A (2012) Apparent mineralocorticoid excess syndrome: report of one family with three affected children. J Pediatr Endocrinol Metab 25:1083–1088
Razzaghy-Azar M, Yau M, Khattab A, New MI (2017) Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. J Steroid Biochem Mol Biol 165:145–150
Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S, Bloch M, Patel M, Ewert S, Abdullah W, Toygar A, Mudryi V, Al Badi M, Alzubdi M, Wilson RC, Al Azkawi HS, Ozdemir HN, Abu-Amer W, Hertecant J, Razzaghy-Azar M, Funder JW, Al Senani A, Sun L, Kim SM, Yuen T, Zaidi M, New MI (2017) Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A 114:11248–11256
Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583–585
Funder JW (2007) Why are mineralocorticoid receptors so nonselective? Curr Hypertens Rep 9:112–116
Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, Krozwski ZS, Funder JW, Shackleton CH, Bradlow HL, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Akkurt HI, De Santis C, New MI (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254
Werder E, Zachmann M, Vollmin JA, Veyrat R, Prader A (1974) Unusual steroid excretion in a child with low renin hypertension. Res Steroids 6:385–389
New MI, Levine S, Biglieri EG, Pareira J, Ulick S (1977) Evidence for an unidentified steroid in a child with apparent mineralocortioid hypertension. J Clin Endocrinol Metab 44:924–933
Ulick S, Ramirez LC, New MI (1977) An abnormality in steroid reductive metabolism in a hypertensive syndrome. J Clin Endocrinol Metab 44:799–802
Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266
Baudrand R, Vaidya A (2018) The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor. Int J Mol Sci 11:19
Breiderhoff T, Himmerkus N, Stuiver M, Mutig K, Will C, Meij IC, Bachmann S, Bleich M, Willnow TE, Müller D (2012) Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis. Proc Natl Acad Sci U S A 109:14241–14246
Meyers N, Nelson-Williams C, Malaga-Dieguez L, Kaufmann H, Loring E, Knight J, Lifton RP, Trachtman H (2019) Hypokalemia associated with a Claudin 10 mutation: a case report. Am J Kidney Dis 73:425–428
Rogers SL, Hughes BA, Jones CA, Freedman L, Smart K, Taylor N, Stewart PM, Shackleton CH, Krone NP, Blissett J, Tomlinson JW (2014) Diminished 11β-hydroxysteroid dehydrogenase type 2 activity is associated with decreased weight and weight gain across the first year of life. J Clin Endocrinol Metab 99:821–831
Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN (2017) The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136:665–767
Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347:88–91
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Patient confidentiality
The patient’s parents provided informed consent for publication of the submitted article and the results of the accompanying genetic analyses.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-019-04326-3.
Rights and permissions
About this article
Cite this article
Kucuk, N., Yavas Abalı, Z., Abalı, S. et al. A rare cause of hypertension in childhood: Answers. Pediatr Nephrol 35, 79–82 (2020). https://doi.org/10.1007/s00467-019-04329-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04329-0